Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    7:30 AM – 8:30 AM Eastern Time
    MTP03A: Meet the Professor: Myositis
    Location: Room 154B
    Seminar Presenter: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 1 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0319: Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis
    Abstract Poster Presenter: May Choi, MD, FRCPC, MPH – University of Calgary
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0320: Comparative Transcriptional Profiling Reveals Shared Pathway Activation Between Human Jo-1+ Anti-Synthetase Syndrome and Murine Histidyl-tRNA Synthetase-Induced Myositis
    Abstract Poster Presenter: Iago Pinal-Fernandez, MD, PhD – NIAMS/National Institutes of Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0321: Diffusion Weighted Imaging in Muscle MRI Can Detect Quantitative Improvements in Muscle Edema: A Post-hoc Analyses of the Study of Tofacitinib in Refractory Dermatomyositis
    Abstract Poster Presenter: Anshula Nallapati, BS – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0322: Enhanced Detection of Myocarditis in Idiopathic Inflammatory Myopathies Utilizing Multiparametric Cardiac Magnetic Resonance Imaging
    Abstract Poster Presenter: Julie Paik, MD, MHS – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0323: Pain Prevalence and Factors Associated with Pain Levels in Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Didem Saygin, MD – Rush University Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0324: Correlative Studies of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials
    Abstract Poster Presenter: Daniel Nunez, PhD (he/him/his) – Cabaletta Bio
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0325: The Impact of Polymyositis and Dermatomyositis in Patients Hospitalized with Inflammatory Bowel Disease: A Nationwide Inpatient Database Analysis
    Abstract Poster Presenter: Nattanicha Chaisrimaneepan, MD (she/her/hers) – Texas Tech University Health Sciences Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0326: Validity and Responsiveness of Core Set Measures in Idiopathic Inflammatory Myositis Based on 36-item Short Form Health Survey (SF-36)
    Abstract Poster Presenter: Maha Almackenzie, MBBS – Security Forces Hospital, SA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0327: Clinical and Immunological Risk Factors Associated with Fybromialgia in Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Samuel Govea-Peláez, -None-, MD – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0328: IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease
    Abstract Poster Presenter: Melissa Leeolou, BS (she/her/hers) – Stanford University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0329: Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials: Future Steps for Equitable Representation by the MIHRA Global Equity and Clinical Trial Readiness Cores
    Abstract Poster Presenter: Manuel Carpio Tumba, MD – University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0330: Baseline Interstitial Lung Disease (ILD) Characteristics and Outcomes in Patients with Anti-synthetase Syndrome Related ILD (ASSD-ILD): Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
    Abstract Poster Presenter: Francisca Bozan, MD – Hospital Clinico Universidad de Chile
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0331: Cardiac Manifestations in Patients with Anti-Synthetase Syndrome: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0332: Predictors of Long-term Radiographic Changes in Patients with Idiopathic Inflammatory Myopathies Using Quantitative Imaging Analysis: Real World Experience from a Single Center Longitudinal Cohort
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0333: Predictors of Transplant-Free Survival in Idiopathic Inflammatory Myopathies- associated Interstitial Lung Disease
    Abstract Poster Presenter: Irada Choudhuri, MD (she/her/hers) – University of Pittsburgh Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0334: Normal Creatine Kinase in Idiopathic Inflammatory Myopathies- Patient Characteristics and Disease Activity
    Abstract Poster Presenter: Shiri Keret, MD (she/her/hers) – Bnai Zion
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0335: Analysis of the Prevalence of Diabetes Mellitus in Patients with Adult-onset Dermatomyositis
    Abstract Poster Presenter: Komal Ejaz, MD – Piedmont
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0336: Mortality: Comparison, Causes and Determinants in Subgroups of Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Gregory Pugnet, MD;PhD – Toulouse Rangueil University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0337: Characterization of Statin Induced Myopathy in the Hospital Setting
    Abstract Poster Presenter: Olivia Yang, MD – HCA/Riverside Community Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0338: Anti-MDA5 Antibody-positive Dermatomyositis Associated Interstitial Lung Disease - Survival Benefit of Treatment with Rituximab, Janus Kinase Inhibitor and Glucocorticoid Combination in a Prospective Cohort
    Abstract Poster Presenter: Cheryl Ng, MBChB, MRCP – Queen Elizabeth Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0339: Clinical Characteristics Associated with Inpatient Mortality in Dermatomyositis Patients: A Single Center Retrospective Cohort Study
    Abstract Poster Presenter: Anjana Srikumar, BA – Johns Hopkins University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0340: Progressive Pulmonary Fibrosis Predicts Mortality in Myositis-Associated Interstitial Lung Disease
    Abstract Poster Presenter: Yu-Wan Liao, MD – Taichung Veterans General Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0341: Efficacy and Safety of Nintedanib in Patients with Idiopathic Inflammatory Myopathy-related Interstitial Lung Disease
    Abstract Poster Presenter: Kaito Aoki, MD – Tokai University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0342: Measurement of Serum Cytokine and Chemokine Level to Predict Poor Treatment Response in Patients with Idiopathic Inflammatory Myositis
    Abstract Poster Presenter: Sung Ik Cho, MD (he/him/his) – Seoul National University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0343: An Interlaboratory Variability Study of Detection Methods for Myositis-Specific and Myositis-Associated Autoantibodies in Sera from Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Georgina Harvey, BSc, PhD, MSc – University of Bath
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0344: Characteristics of Patients with Antisynthetase Antibodies
    Abstract Poster Presenter: Danny Kasto, MBChB – Wollongong hospital, NSW
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0345: Treatment Patterns and Glucocorticoid Burden of Dermatomyositis Patients: A Cohort Study in the University of Pittsburgh's Myositis Registry
    Abstract Poster Presenter: Rohit Aggarwal, MD;MS (he/him/his) – Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0346: Clonally Expanded and Total B Cells in Patients with Idiopathic Inflammatory Myopathies Show Skewed B Cell Subset Distribution and Reduced Somatic Hypermutation Relative to Healthy Controls
    Abstract Poster Presenter: Amelia Sawyers, BA – Vanderbilt University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0347: Dermato-polymyositis Mortality in U.S. Population: Declining Cancer and Cardiovascular Diseases Among the Leading Underlying Causes of Death over Two Decades
    Abstract Poster Presenter: Elizabeth Matz, -None- – University of California, Los Angeles
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0348: Upadacitinib in Interstitial Lung Disease Associated with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Ting Zhang, MD (she/her/hers) – The second affiliated hospital, Zhejiang University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    11:30 AM – 12:30 PM Eastern Time
    MTP03B: Meet the Professor: Myositis
    Location: Room 154B
    Seminar Presenter: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 1 hours
  • Saturday, Nov 16th
    3:00 PM – 4:30 PM Eastern Time
    16S44: Spectrum of CTD-ILD: From Early Diagnosis to Lung Transplant
    Location: Hall D/E
    Moderator: Rachel Wallwork, MD, MHS (she/her/hers) – Johns Hopkins University
    Moderator: Erin Wilfong, MD, PhD – Vanderbilt University Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 1.5 hours
  • Saturday, Nov 16th
    3:00 PM – 3:30 PM Eastern Time
    Therapeutic Considerations in Rapidly Progressive CTD-ILD
    Location: Hall D/E
    Speaker: Takahisa Gono, MD – Nippon Medical School Graduate School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    3:30 PM – 4:00 PM Eastern Time
    Role of Immunosuppression and Antifibrotics in the Treatment of CTD-ILD
    Location: Hall D/E
    Speaker: Ganesh Raghu, MD – University of Washington
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Saturday, Nov 16th
    4:00 PM – 4:30 PM Eastern Time
    Consideration and Timing of Lung Transplant in CTD-ILD
    Location: Hall D/E
    Speaker: Sonye Danoff, MD, PhD, MPhil – Johns Hopkins Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1139: Comprehensive Single-cell Profiling of Diverse Circulating Immune Cells in Idiopathic Inflammatory Myopathies Identifies a Novel Pathogenic Subset of Monocytes
    Abstract Poster Presenter: Shinji Izuka, MD (he/him/his) – University of Tokyo
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1140: Pulmonary Hypertension in Hospitalized Patients with Dermatomyositis & Polymyositis: A Nationwide Cohort Analysis
    Abstract Poster Presenter: Saman Tanveer, MD – John H. Stroger Jr. Hospital of Cook County
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1141: Defining a Novel Type of Myositis: Immune Mediated Megaconial Myopathy (IMMM)
    Abstract Poster Presenter: Teerin Liewluck, MD (he/him/his) – Mayo Clinic
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1142: Disease Trajectory in anti-MDA5 Dermatomyositis Patients Presented with Different Stage of Interstitial Lung Disease
    Abstract Poster Presenter: TING-YUAN LAN, MD – National Taiwan University Hospital Hsinchu Branch
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1143: Epidemiology and Spectrum of Idiopathic Inflammatory Myopathies in Individuals of Sub-Saharan Ancestry: Data from the Tertiary Care Center of the Caribbean Island of Martinique
    Abstract Poster Presenter: Benoit Suzon, M.D. – University Hospital of Martinique
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1144: Autoantibody and Radiological Profiles as Prognostic Indicators in Idiopathic Inflammatory Myopathies: Insights into Mortality and Interstitial Lung Disease Development
    Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Complejo Asistencial Universitario de León
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1145: Clinico-Immunological Profile and Treatment Outcomes of Clinically Significant Diaphragmatic Weakness in Patients with Idiopathic Inflammatory Myopathies: Results from the Largest Single-Center Cohort of 16 Cases
    Abstract Poster Presenter: Siddharth Jain, MD, DM, MRCP – All India Institute of Medical Sciences, New Delhi
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1146: Impact of COVID-19 on Myositis Testing Trends
    Abstract Poster Presenter: Angel Kevin Garza-Elizondo, MD (he/him/his) – Facultad de Medicina, Universidad Autonoma de Nuevo Leon
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1147: Evaluation of Adverse Pregnancy Outcomes in Patients with Inflammatory Myopathies and Ro Positivity
    Abstract Poster Presenter: Ana Valle, MD,MHS – Brigham and Women's Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1148: Simplified Cutaneous Dermatomyositis Disease Area and Severity Index Activity Scores for Cutaneous Dermatomyositis
    Abstract Poster Presenter: Nantakarn Pongtarakulpanit, MD (she/her/hers) – Mahidol University, University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1149: Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Ansaam Daoud, MD – Case Western Reserve University/University Hospitals
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1150: Increased ISG15 Expression in Peripheral Blood from Patients with Positive Dermatomyositis Related Specific Autoantibodies
    Abstract Poster Presenter: Sylvia Raftopoulou, BSc, MSc – National and Kapodistrian University of Athens
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1151: Clinical Characterization and Recurrence Prediction Model for Immune-Mediated Necrotizing Myopathy
    Abstract Poster Presenter: Qibing Xie, West China Hospital – Department of Rheumatology and Immunology
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1152: Nailfold Videocapillaroscopy Abnormalities in Different Autoimmune Inflammatory Myopathy Subsets
    Abstract Poster Presenter: Valerie Leclair, MD, PhD – McGill University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1153: Increased Prevalence of Myositis Specific and Associated Autoantibodies in Patients with Interstitial Lung Disease of Unknown Etiology
    Abstract Poster Presenter: Clio Mavragani, MD – National and Kapodistrian University of Athens
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1154: Comparative Transcriptome Analysis of Murine Model and Human Samples in Anti-Melanoma Differentiation Associated Gene 5 Antibody-positive Rapidly Progressive Interstitial Lung Disease
    Abstract Poster Presenter: Yuki Ichimura, MD, PhD – Institute of Science Tokyo
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1155: Stratification of Cancer Risk in Idiopathic Inflammatory Myopathies. Application of the IMACS Guidelines to Enhance Screening
    Abstract Poster Presenter: Miriam Retuerto Guerrero, MD (she/her/hers) – Complejo Asistencial Universitario de León
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1156: Prevalence and Impact of Fibromyalgia in Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Didem Saygin, MD – Rush University Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1157: Reduced Statin Use in Patients with Autoimmune Myopathies and Systemic Lupus Erythematosus Compared to Rheumatoid Arthritis and Non-Inflammatory Diseases
    Abstract Poster Presenter: Shane Cameron, MD – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1158: Microvascular Differences Between Cancer and Non-cancer Anti-transcriptional Intermediary Factor 1 Gamma Antibody (anti-TIF1-γ) Associated Dermatomyositis Patients
    Abstract Poster Presenter: Sehreen Mumtaz, MD,MBBS – Mayo Clinic, Florida
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1159: Anti-synthetase Syndrome (ASSD) Related Interstitial Lung Disease (ILD) in Comparison to Non-ASSD Related ILDs: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1160: Short Form-36 Psychometric Properties in Idiopathic Inflammatory Myopathies: Reliability, Validity and Responsiveness
    Abstract Poster Presenter: Shiri Keret, MD (she/her/hers) – Bnai Zion
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1161: Characterization of the Clinical Presentation of Idiopathic Inflammatory Myopathies According to the Profile of Specific Autoantibodies with Multiple Positivity
    Abstract Poster Presenter: Adriana Miguel Álvarez, MD (she/her/hers) – Instituto Nacional de Cardiología "Ignacio Chávez"
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1162: Evaluating the Efficacy of Rituximab in the Treatment of Refractory Adult Idiopathic Inflammatory Myositis Using Total Improvement Score: Data from a Real-World Multi-Centre Registry in the United Kingdom
    Abstract Poster Presenter: Xia Lyu, MD (she/her/hers) – Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1163: Characteristics of Interstitial Lung Disease Progressors in an Antisynthetase Autoantibody-Positive Population
    Abstract Poster Presenter: Aurélie Mourot, MD – Centre Hospitalier de l'Université de Montréal (CHUM)
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1164: IVIG Treatment Duration in Immune-mediated Necrotizing Myopathy and a Possible Association of Vacuolar Changes with Black/African American Female Patients
    Abstract Poster Presenter: Asim Mohamed, MD, MBA – PGY5
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1165: Dysregulation of Peripheral Blood B-cells Is Associated with Myocarditis in Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Julie Paik, MD, MHS – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1166: Characteristics, Treatments, and Outcomes of Patients with Dermatomyositis from Two Large, Nationwide US Cohorts
    Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1167: Construction of a Refractory Myositis Predictive Index (ReMPI) in a Cohort of Patients with Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Andres Gaytan Garcia de Alba, MD – Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1168: Improved Survival in Patients with Myositis-Associated Interstitial Lung Disease (ILD) During the Period 2011 to 2023: Comparative and Integrative Analysis of Three Multicenter Cohorts in Japan
    Abstract Poster Presenter: Masataka Kuwana, MD,PhD – Nippon Medical School Graduate School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1169: Efficacy of Intravenous Immunoglobulin (Octagam 10%) on Pulmonary Manifestations in Patients with Dermatomyositis: Results from the ProDERM Study
    Abstract Poster Presenter: Rohit Aggarwal, MD;MS (he/him/his) – Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1170: Computer Aided Lung Informatics, HRCT and PFT in Patients with Interstitial Lung Disease in Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Sonali Narain, MD, MPH – Northwell Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    3:00 PM – 4:30 PM Eastern Time
    17S63: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I
    Location: Room 145AB
    Abstract Moderator: Dana Ascherman, MD – University of Pittsburgh
    Abstract Moderator: Siamak Moghadam-Kia, MD, MPH – University of Pittsburgh Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 0 hours
  • Sunday, Nov 17th
    3:00 PM – 3:15 PM Eastern Time
    1731: Baricitinib in the Treatment of Adult Idiopathic Inflammatory Myopathy: A Randomized, Treatment Delayed-Start Clinical Trial
    Location: Room 145AB
    Presenting Author: Hector Chinoy, PhD, MBBS, MSc, FRCP (he/him/his) – The University of Manchester
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    3:15 PM – 3:30 PM Eastern Time
    1732: In Vitro Screening of siRNAs Designed to Knockdown Interferon Beta as a Novel Therapeutic Approach for Treatment of Adult and Juvenile Dermatomyositis
    Location: Room 145AB
    Presenting Author: Joanna Parkes, PhD – MRC Nucleic Acid Therapy Accelerator
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    3:30 PM – 3:45 PM Eastern Time
    1733: Safety and Efficacy of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials
    Location: Room 145AB
    Presenting Author: David Chang, MD, MPH, FACR – Cabaletta Bio
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    3:45 PM – 4:00 PM Eastern Time
    1734: Safety and Efficacy Data from a Phase I Trial of Umbilical Lining-Derived Stem Cells (ULSC) in Adult Dermatomyositis/Polymyositis
    Location: Room 145AB
    Presenting Author: Michael Bubb, MD – University of Florida
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    4:00 PM – 4:15 PM Eastern Time
    1735: High-Intensity Interval Training Outperforms Moderate Exercise in Aerobic Capacity for Recent-Onset Idiopathic Inflammatory Myopathies: A Randomized Controlled Trial
    Location: Room 145AB
    Presenting Author: Kristofer Andreasson, PT, MSc – Karolinska Institutet
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 17th
    4:15 PM – 4:30 PM Eastern Time
    1736: Effectiveness and Safety of Tofacitinib vs. Calcineurin Inhibitor in Interstitial Lung Disease Secondary to Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis: A Multi-Center Cohort Study with Propensity Score-Based Inverse Probability of Treatment Weighting
    Location: Room 145AB
    Presenting Author: Xia Lyu, MD (she/her/hers) – Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2058: Association of Anti-Synthetase Antibody Subtypes with Radiographic Progression of Interstitial Lung Disease in Anti-Synthetase Syndrome: An Analysis of the CLASS Project Database
    Abstract Poster Presenter: Daphne Rivero Gallegos, MD – INER
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2059: The Rs35705950 Promoter Variant of Muc5b Is Associated with Usual Interstitial Pneumonia in Antisynthetase Syndrome
    Abstract Poster Presenter: Daphne Rivero Gallegos, MD – INER
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2060: Clustering Analysis of Immune Cell Subtypes and Clinical Phenotypes in Idiopathic Inflammatory Myopathy
    Abstract Poster Presenter: Jing He, MD – Rheumatology
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2061: Associations Between Intramyocellular Lipid and Muscle Function in Patients with Osteoarthritis
    Abstract Poster Presenter: Rachel Gillcrist, MPH (she/her/hers) – Dartmouth College
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2062: Performance of the Patient Self-Assessment Tools for Cutaneous Dermatomyositis: Patient CDASI and Rash Mapping
    Abstract Poster Presenter: Nantakarn Pongtarakulpanit, MD (she/her/hers) – Mahidol University, University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2063: Serum Glutamate Dehydrogenase in Idiopathic Inflammatory Myopathy Patients
    Abstract Poster Presenter: Nantakarn Pongtarakulpanit, MD (she/her/hers) – Mahidol University, University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2064: Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach
    Abstract Poster Presenter: Nantakarn Pongtarakulpanit, MD (she/her/hers) – Mahidol University, University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2065: Proposed Pathways Involved in the Pathogenesis of Juvenile Dermatomyositis (JDM)
    Abstract Poster Presenter: Samantha Coss, MD, PhD (she/her/hers) – Nationwide Children's Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2066: Comparative Diagnostic Efficacy of Quantitative Measurement of Echo Intensity and Texture versus Qualitative Analysis of Ultrasound Images in Myositis
    Abstract Poster Presenter: Takeshi Yoshida, MD, PhD – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2067: Clinical and Laboratory Characterization of Overlap Connective Tissue Disease in Patients with Idiopathic Inflammatory Myopathies: Results from the MYOTReCSZ Cohort
    Abstract Poster Presenter: karina santana, MD, MSc – INCMNSZ
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2068: Poloxamers 188 & 182 Are Effective in Repairing the Membrane Resealing Defect in Myositis
    Abstract Poster Presenter: Shane Bruckner, PhD – OSU
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2069: Cancer Risk and Screening Effectiveness in Idiopathic Inflammatory Myopathy: Validating IMACS Guidelines in a Retrospective Indian Cohort
    Abstract Poster Presenter: Lovely Kumari, MD (she/her/hers) – Jawaharlal Institute of Postgraduate Medical Education and Research,PUDUCHERRY
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2070: Increased Circulating Levels of Fatty Acid-binding Proteins as a Potential Biomarker of Disease Damage in Inflammatory Myopathies Patients
    Abstract Poster Presenter: Margherita Giannini, MD, PhD (she/her/hers) – Nouvel Hopital Civil, Strasbourg
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2071: Self-Efficacy Contributes to Better Health Outcomes in Patients of Idiopathic Inflammatory Myopathies: Insights from the COVAD 3 Dataset
    Abstract Poster Presenter: Praggya Yaadav, MBBS (she/her/hers) – MIMSR Latur
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2072: Clinical and Laboratory Features Associated with Pulmonary Involvement in Patients with Inflamatory Myopathy
    Abstract Poster Presenter: Sonja Praprotnik, MD, PhD – University Medical Centre Ljubljana
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2073: Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison
    Abstract Poster Presenter: Alejandra Espinosa-Orantes, MB – Instituto Nacional de Rehabilitación
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2074: Experience on the Use of Obinutuzumab off Label in Patients with Refractory Idiopathic Inflammatory Myopathy
    Abstract Poster Presenter: Ivana Ilic, MD – Northwell
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2075: A Retrospective Cohort Study Assessing Outcomes and Safety in Patients Receiving Low Dose vs High Dose Cyclophosphamide in Myositis Interstitial Lung Disease (ILD)
    Abstract Poster Presenter: Saadia Sasha Ali, MSc, MBChB (she/her/hers) – King's College Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2076: Comparing the Efficacy of Conventional Immunosuppression and Rituximab in Anti-SRP Myositis: Insights from a Tertiary Care Centre Experience
    Abstract Poster Presenter: ABHILASHA ARVIND MANWATKAR, DM – christian medical college
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2077: Comparison of Janus Kinase Inhibitors to Block the Type I and II Interferon Pathways in Human Myoblasts
    Abstract Poster Presenter: Travis Kinder, PhD – National Institutes of Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2078: Increased RAGE Expression in Myositis
    Abstract Poster Presenter: Madison King, BS (she/her/hers) – Binghamton University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2079: Understanding Relapse Patterns in Anti-HMGCR Statin-induced IMNM: A Detailed Comparative Study
    Abstract Poster Presenter: Silvia Grazzini, MD – University of Siena
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2080: HLA-DRB1*11:01 Association Differenciates Anti-hmgcr Immune-mediated Necrotizing Myopathy from Non-immune Mediated Statin Myotoxicity
    Abstract Poster Presenter: Cristina Corrales, MD – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2081: Proteomic Profiling of Urine Reveals Biomarker Candidates for Idiopathic Inflammatory Myopathies
    Abstract Poster Presenter: Xueting Yuan, MD – Peking Union Medical College & Chinese Academy of Medical Sciences
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2082: Different Clinical Phenotypes of Patients with Anti-synthetase Syndrome: Unsupervised Cluster Analysis in the CLASS Database
    Abstract Poster Presenter: Akira Yoshida, MD – Nippon Medical School Graduate School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2083: A Novel Scoring System to Predict a Cancer Development in Patients with Idiopathic Inflammatory Myopathy
    Abstract Poster Presenter: Jun Won Park, MD (he/him/his) – Seoul National University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2084: Efficacy and Safety of a Step-down Regimen of Low Dosage of Glucocorticoids Combined with Early Administration of Synthetic or Biologic Immunosuppressants in Anti-synthetase Syndrome: A Pilot Study
    Abstract Poster Presenter: Edoardo Conticini, MD – Università di Siena
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2085: The Effects of Pioglitazone on Metabolic Dysregulation in Inclusion Body Myositis: An Open-Label Pilot Study
    Abstract Poster Presenter: Brittany Adler, MD – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2086: Specific Transcriptomic Profile Associated with Disease Activity in Muscle Biopsies from Patients with Sarcoid Myopathy
    Abstract Poster Presenter: Iago Pinal-Fernandez, MD, PhD – NIAMS/National Institutes of Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    3:30 PM – 4:30 PM Eastern Time
    18M48: Harnessing Autoantibody Tests in Myositis: Clinical Nuances, Limitations, and Novel Directions
    Location: Ballroom C
    Moderator: David Fernandez, MD, PhD – Hospital for Special Surgery
    Moderator: Julie Paik, MD, MHS – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 1 hours
  • Monday, Nov 18th
    3:30 PM – 3:50 PM Eastern Time
    Comparing the Performance of ELISA-Based and Immunoprecipitation-Based Assays for Myositis Autoantibody Detection
    Location: Ballroom C
    Speaker: Sarah Tansley, PhD; BSc; MBChB – University of Bath
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    3:50 PM – 4:10 PM Eastern Time
    Threshold Effects and Interpretation of Myositis Autoantibody Results
    Location: Ballroom C
    Speaker: Christopher Mecoli, MD – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 18th
    4:10 PM – 4:30 PM Eastern Time
    Unique Muscle Histopathological Features Associated with Autoantibody Subtypes
    Location: Ballroom C
    Speaker: Tahseen Mozaffar, MD (he/him/his) – The University of California, Irvine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    11:00 AM – 12:30 PM Eastern Time
    19T13: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II
    Location: Room 145AB
    Abstract Moderator: Jisna Paul, MD – Ohio State University Hospital
    Abstract Moderator: Iago Pinal-Fernandez, MD, PhD – NIAMS/National Institutes of Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME 0 hours
  • Tuesday, Nov 19th
    11:00 AM – 11:15 AM Eastern Time
    2665: Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
    Location: Room 145AB
    Presenting Author: Tsuneo Sasai, MD – Kyoto University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    11:15 AM – 11:30 AM Eastern Time
    2666: The Risk for Development of Myositis Is Not Increased After COVID-19 Vaccination Among U.S. Veterans
    Location: Room 145AB
    Presenting Author: Caleb Hernández, MD – University of Utah
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    11:30 AM – 11:45 AM Eastern Time
    2667: Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein
    Location: Room 145AB
    Presenting Author: Jon Musai, BS (he/him/his) – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    11:45 AM – 12:00 PM Eastern Time
    2668: Do Levels of anti-Jo1 Autoantibodies Have a Prognostic Role? Longitudinal Assessment of anti-Jo1 and HisRS Protein Levels in a Cohort of anti-Jo1 Positive Patients with Anti-synthetase Syndrome
    Location: Room 145AB
    Presenting Author: Antonella Notarnicola, MD,PhD (she/her/hers) – Karolinska University Hospital and Karolinska Institutet
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    12:00 PM – 12:15 PM Eastern Time
    2669: Dysferlin Autoantibodies Compromise Sarcolemmal Repair Capacity and Contribute to the Pathogenesis of Idiopathic Immune Myopathies
    Location: Room 145AB
    Presenting Author: Hannah Bulgart, BS – The Ohio State University Wexner Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 19th
    12:15 PM – 12:30 PM Eastern Time
    2670: Sera from Patients with Idiopathic Inflammatory Myopathy Induces Muscle Weakness, Mitochondrial Dysfunction and Induction of Cytokines in Isolated Skeletal Muscle
    Location: Room 145AB
    Presenting Author: Daniel C. Andersson, MD,PhD – Karolinska Institutet
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)